SEC Tracker
Get the app
ICU · XBRL financial data

SeaStar Medical Holding financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ICU's year ends in late December)

In thousands of dollarsSep 30, 2023†Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025†Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers00*006867*293338183420*495615
Cost of goods and services sold00*0000*0271412*4654
Gross profit—0*006867*293311169408*449561
Research and development1,1071,075*1,6972,3342,3362,738*2,4311,0371,8502,200*2,3442,520
General and administrative1,8291,868*2,2532,3352,1882,096*1,6841,0301,8981,224*1,7081,832
Total operating expenses2,9362,943*3,9504,6694,5244,834*4,1152,0673,7483,424*4,0524,352
Operating income (loss)(2,936)(2,943)*(3,950)(4,669)(4,456)(4,767)*(3,822)(1,756)(3,579)(3,016)*(3,603)(3,791)
Interest income00*0255819*4845107125*9169
Interest expense224199*14382272(253)*119013*68
Other income (expense)(4,490)(6,937)*(8,747)1,436(22)348*53(246)————
Income tax expense (benefit)0(5)*0300*3000*30
Net income (loss)(7,426)(9,875)*(12,697)(3,236)(4,478)(4,419)*(3,772)(2,002)(3,472)(2,904)*(3,521)(3,730)
Earnings per share, basic‡ USD per share(9.25)—(4.75)(1.03)(1.10)—(0.44)(0.18)(0.13)—(0.90)(0.91)
Earnings per share, diluted‡ USD per share(9.25)—(4.75)(1.03)(1.10)—(0.44)(0.18)————
Weighted average shares, basic‡ thousands of shares802—2,6843,1554,087—8,61811,33026,393—3,9184,084
Weighted average shares, diluted‡ thousands of shares802—2,6843,1554,087—8,61811,330————
  • ‡ Per-share figures and share counts are adjusted for the 1-for-25 stock split (June 2024); filings made before it reported them unadjusted.
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/9 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (ICU's year ends in late December)

In thousands of dollarsSep 30, 2023†Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025†Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents731765,0191,1792,0821,8195,2966,30213,76311,9809,3486,959
Accounts receivable—0——68112110217221237179208
Inventory————00447783665777
Total current assets2,2452,3086,5372,4143,6163,7666,7847,64714,87413,58010,7648,228
Total assets2,2473,5137,7403,4674,5864,6587,5978,38315,53014,15811,2638,649
Accounts payable5,0424,3723,8794,1173,6873,0463,3973,1582,018948719750
Accrued liabilities1,4811,5231,5442,2582,2913,1883,2551,8832,0472,2682,8973,468
Current portion of long-term debt—565———574——————
Total current liabilities12,42813,0469,6489,9306,6386,8417,0325,0424,0663,7423,9484,353
Total liabilities18,15017,38312,21310,3686,6386,8417,0325,0424,0663,7423,9484,353
Accumulated deficit(115,682)(114,734)(127,431)(130,667)(135,145)(139,564)(143,336)(145,338)(148,810)(151,714)(155,235)(158,965)
Total stockholders' equity(15,903)(13,870)(4,473)(6,901)(2,052)(2,183)5653,34111,46410,4167,3154,296
Total liabilities and equity2,2473,5137,7403,4674,5864,6587,5978,38315,53014,15811,2638,649
Common shares outstanding (cover page)‡ thousands of shares1,4793,0173,0174,1694,4638,72110,56427,91536,0473,9943,9974,407
  • ‡ Per-share figures and share counts are adjusted for the 1-for-25 stock split (June 2024); filings made before it reported them unadjusted.
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/9 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (ICU's year ends in late December)

In thousands of dollarsSep 30, 2023†Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025†Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(7,426)(9,875)*(12,697)(3,236)(4,478)(4,419)*(3,772)(2,002)(3,472)(2,904)*(3,521)(3,730)
Stock-based compensation484*386*43441*200*212*16797*290*70*91(99)*
Net cash from operating activities(1,337)*(4,485)*(3,488)(2,824)*(5,002)*(4,693)*(2,654)(3,007)*(3,844)*(4,094)*(2,761)(2,994)*
Proceeds from issuing common stock120*3,459*4,543(51)*9,090*3,859*1,5663,588*9,183*1,789*329810*
Proceeds from long-term debt——1,0870*0*0*——————
Net cash from financing activities1,397*4,588*8,331(1,016)*5,905*4,430*6,1314,013*11,305*2,311*129605*
Net change in cash—————(263)*3,4771,006*7,461*(1,783)*(2,632)(2,389)*
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/9 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
SeaStar Medical Holding6,959615(2,994)*4.4M2.3 quarters 10-QJun 30, 2026
ENvue Medical1,084239(2,691)*11.1M0.4 quarters 10-QJun 30, 2026
Tenon Medical1,6771,279(2,758)*667,0470.6 quarters 10-QJun 30, 2026
Bone Biologics6,088not reported(532)*3.4M9.8 quarters 10-QSep 30, 2026
Sintx Technologies3,590452(2,767)*6.7M1.3 quarters 10-QJun 30, 2026
OSR Health1,500316(2,421)*35.1M0.6 quarters 10-QJun 30, 2026
Adm Tronics Unlimited223not reported(33)67.6M6.8 quarters 10-QJun 30, 2026
Retractable Technologies2,6417,201(1,732)*29.9M1.5 quarters 10-QJun 30, 2026
Sonoma Pharmaceuticals5,3386,406(649)4.8M8.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.